top of page
More than 25 programs in development
We are committed to developing new therapies and solutions for a wide range of patients in different fields. Rafarma Pharmaceuticals group of companies has run more than 25 programs in several areas, including molecular biology, nuclear medicine, immunology, sustainable packaging, and others.
(OTC Markets Group)
group of companies
bottom of page